2017
DOI: 10.1016/j.ijbiomac.2016.06.016
|View full text |Cite
|
Sign up to set email alerts
|

Aggregative protein–polyelectrolyte complex for high-concentration formulation of protein drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(20 citation statements)
references
References 64 publications
0
20
0
Order By: Relevance
“…Similarly, an emulsion state of protein–polyelectrolyte complex (PPC) has been developed for the formulation of high-concentration protein drugs [ 125 ]. The molecular mechanism of PPC formation is only from electrostatic interaction.…”
Section: Cluster and Aggregatesmentioning
confidence: 99%
“…Similarly, an emulsion state of protein–polyelectrolyte complex (PPC) has been developed for the formulation of high-concentration protein drugs [ 125 ]. The molecular mechanism of PPC formation is only from electrostatic interaction.…”
Section: Cluster and Aggregatesmentioning
confidence: 99%
“…The supernatant of the redissolved solution, including purified CspB fusion protein, is collected (step 5), leaving irreversibly precipitated insoluble impurities. Note that the highly reversible pH-dependent aggregation is used as a protein concentration method [33,34]. When a small amount of buffer is added in steps 3-4, the CspB fusion protein is easily concentrated.…”
Section: Costless Methods Compared With Chromatographymentioning
confidence: 99%
“…High concentration of proteins can also be stored in protein–PE aggregate precipitates [22]. Kurinomaru et al obtained high concentration of proteins (panitumumab, etanercept, thyroglobulin and others) in complexes by precipitation with cationic and anionic PEs (poly-L-lysine and poly-L-glutamic acid) followed by redissolution of the complexes in high salt environments (Figure 6a) without any significant changes in the activities of the proteins and antibodies [114].…”
Section: Protein–polyelectrolyte Bulk Complexesmentioning
confidence: 99%
“…Recent advances in polymer synthesis, biotechnology and characterization techniques coupled with the unique and advantageous attributes of protein–PE complexes have contributed immensely towards the widespread use of bulk phase separated protein–PE complexes in myriad biotechnological applications. These include protein separation, purification and concentration [3,18,19], protein stabilization [20,21,22,23], drug/protein delivery [24,25,26], synthetic bio-adhesives [27,28,29], tissue engineering [30], gene therapy [31] and encapsulants in the food industry [1,32,33].…”
Section: Introductionmentioning
confidence: 99%